Pre Next

[1] LI Feifei ZHENG Yuanfang TAN Hongzhen,.Effects of Sanyin Decoction on Arterial Blood Gas Analysis in Patients with Chronic Obstructive Pulmonary Disease in Stable Stage [J]. Modern Traditional Chinese Medicine, 2021, (04): 81-85. [doi: 10.13424/j.cnki.mtcm.2021.04.019]

Copy

Effects of Sanyin Decoction on Arterial Blood Gas Analysis in Patients with Chronic Obstructive Pulmonary Disease in Stable Stage

Modern Traditional Chinese Medicine[ISSN: 1006-6977/ CN: 61-1281/TN] Volumes & Issues: 2021 04 pagination: 81-85 Column: Publication date: 2023-11-20

Article number:: 1672-0571(2021)04-0081-05

Author(s):: LI Feifei¹ ZHENG Yuanfang² TAN Hongzhen ²; 1.Changde First Hospital of Traditional Chinese Medicine，Hunan Changde 415000，China;
2.Hunan University of Traditional Chinese Medicine，Changsha 410208，China

Keywords:: Sanyin Decoction; Chronic obstructive pulmonary disease; Stability period; Deficiency syndrome; Randomized controlled trial; Blood gas analysis

ZTFLH:: R256.1

DOI:: 10.13424/j.cnki.mtcm.2021.04.019

Code:: A

Abstract:: Objective To evaluate the effect of Sanyin Decoction on TCM syndrome integral and blood gas analysis in patients with chronic obstructive pulmonary disease (COPD) with deficiency syndrome in stable period.Methods 120 patients with COPD in stable stage were randomly divided into treatment group (60 cases) and control group (60 cases). The control group was treated with conventional western medicine. The treatment group was treated with Sanyin Decoction on the basis of the control group. The therapeutic effect was compared after 6 months. The blood gas analysis of the two groups before and after treatment was observed. Results There was no significant difference between PaO2 of the two groups before treatment，which was comparable. The oxygen pressure of the two groups was improved after treatment than before，and the treatment group was significantly improved than the control group (P<0.05). There was no significant difference between PaCO2 of the two groups before treatment，which was comparable. PaO2 in both groups was improved after treatment than before，and the treatment group was significantly improved than that of the control group (P＜0.05). The comprehensive score of TCM syndrome was comparable with the two groups before treatment. The total score of TCM syndrome in the two groups was lower than before treatment，and the treatment group was significantly improved compared with the control group (P＜0.05).Conclusion Sanyin decoction can improve blood gas condition，improve clinical symptoms and improve quality of life of COPD patients in stable stage.Objective To evaluate the effect of Sanyin Decoction on TCM syndrome integral and blood gas analysis in patients with chronic obstructive pulmonary disease (COPD) with deficiency syndrome in stable period.Methods 120 patients with COPD in stable stage were randomly divided into treatment group (60 cases) and control group (60 cases). The control group was treated with conventional western medicine. The treatment group was treated with Sanyin Decoction on the basis of the control group. The therapeutic effect was compared after 6 months. The blood gas analysis of the two groups before and after treatment was observed. Results There was no significant difference between PaO2 of the two groups before treatment，which was comparable. The oxygen pressure of the two groups was improved after treatment than before，and the treatment group was significantly improved than the control group (P<0.05). There was no significant difference between PaCO2 of the two groups before treatment，which was comparable. PaO2 in both groups was improved after treatment than before，and the treatment group was significantly improved than that of the control group (P＜0.05). The comprehensive score of TCM syndrome was comparable with the two groups before treatment. The total score of TCM syndrome in the two groups was lower than before treatment，and the treatment group was significantly improved compared with the control group (P＜0.05).Conclusion Sanyin decoction can improve blood gas condition，improve clinical symptoms and improve quality of life of COPD patients in stable stage.

References:

［1］柳涛,蔡柏蔷.慢性阻塞性肺疾病诊断、处理和预防全球策略(2011年修订版）介绍［J］.中国呼吸与危重监护杂志,2012,11（1）:1-12.

［2］Fang L，Gao P，Bao H，et al.Chronic obstructive pulmonary disease in China:a nationwide prevalence study［J］.Lancet Respir Med.2018,26(6):421-430.

［3］Wang c,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstmctive pulmonary disease in China(the China Pulmonary Health［cPH］study):national cmss-sectional study［J］.Iancet,2018,391（10131):1706-1717.

［4］Yang G，waIlg Y，zeng Y，et al.Rapid health tmnsition in china,1990-2010：findings from the Global Burden of Disease Study 20l1［J］.Lancet,2013,381(9882):1987-2015.

［5］兰丰铃,王胜锋,曹卫华,等.慢性阻塞性肺疾病危险因素流行病学研究新进展［J］.中华疾病控制杂志,2014,18(10):998-1002.

［6］周玲凤,何庆华,唐海,等.慢性阻塞性肺疾病流行病学调查及防控分析［J］.中国医学创新,2021,18(6):84-87.

［7］吴文彬,陈昌枝,杨冬莲,等.D-二聚体、B型钠尿肽与血气在慢性阻塞性肺疾病继发肺栓塞的预测价值［J］.中华肺部疾病杂志,2019,(6):743-746.

［8］中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2013年修订版）［J］.中国医学前沿杂志,2014,6(2):68-79.

［9］中华中医药学会内科分会肺系病专业委员会.慢性阻塞性肺疾病中医诊疗指南（2011版）［J］.中医杂志,2012,53(1):80-84.

［10］周玉民，王小平，曾祥毅，等.茶碱治疗慢性阻塞性肺疾病的随机双盲平行对照研究［J］.中华结核和呼吸杂志,2006,29(9):577.

［11］郑筱萸.中药新药临床研究指导原则试行［M］.北京:中国医药科技出版社，2002:53-60.

［12］景璇,郭洁,赵小静,等.慢性阻塞性肺疾病急性加重期的中医治疗研究进展［J］.世界中医药,2016,11(7):1384-1388.

［13］李建生.中医临床肺脏病学［M］.北京:人民卫生出版,2015:395.

［14］李建生.正虚积损为慢性阻塞性肺疾病的主要病机［J］.中华中医药,2011,26(8):1710-1713.

［15］李建生,余学庆.慢性阻塞性肺疾病中医分期分级防治策略［J］.中医杂志,2019,60(22):1895-1899.

［16］闫香桂,吴国芳,黄芬,等.中医药治疗稳定期慢性阻塞性肺疾病研究进展［J］.中医学报,2016,31(9):1284-1288.

［17］董杨.定喘方联合西医治疗中度慢性阻塞性肺疾病急性加重期临床效果观察［J］.中医临床研究,2020,12(29):21-23.

［18］江紫媚,周璇,陈斯宁.中医特色外治疗法对慢性阻塞性肺疾病稳定期的研究进展［J］.中医临床研究,2018,10(22):136-140.

［19］涂彬彬,许爱国.RDW、PLR及动脉血气分析在慢性阻塞性肺疾病急性加重期合并肺动脉高压中的临床意义［J］.河南医学研究,2020,35(4):981-984.

［20］程继勇,谭家明,李军文.低分子肝素治疗AECOPD合并呼吸衰竭的疗效、凝血指标、CK-MB及炎性因子表达的临床观察［J］.临床输血与检验,2020,32(2):172-176.

［21］吴文彬,陈昌枝.慢性阻塞性肺疾病并肺栓塞的危险因素及诊治研究现状［J］.中国实用医药,2020,16(6):189-191.

Memo

项目基金：湖南省中医药管理局重点项目（201436）

Last Update: 2021-08-02